Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study
European Journal of Nuclear Medicine · 1991-05 · 18 (5) · 308-316
DOI: 10.1007/bf02285457 ↗Kurz gefasst
Klinische Studie in der Zeitschrift European Journal of Nuclear Medicine, 1991-05. Verfasst von S L Fielding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK. Hauptthemen laut MEDLINE: Radiometry. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK.
Zitieren
APA
Fielding, S. L., Flower, M. A., Ackery, D., Kemshead, J. T., Lashford, L. S., & Lewis, I. (1991). Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine, 18(5), 308-316. https://doi.org/10.1007/bf02285457
Vancouver
Fielding SL, Flower MA, Ackery D, Kemshead JT, Lashford LS, Lewis I. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine. 1991;18(5):308-316. doi:10.1007/bf02285457
BibTeX
@article{Fielding1991,
author = {Fielding, S L and Flower, M A and Ackery, D and Kemshead, J T and Lashford, L S and Lewis, I},
title = {Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study},
journal = {European Journal of Nuclear Medicine},
year = {1991},
volume = {18},
number = {5},
pages = {308--316},
doi = {10.1007/bf02285457}
}
EUVIMED